BioSpace News Archive

RVAC Medicines (US), Inc. today announced the collaboration under a Sponsored Research Agreement with the University of Pennsylvania (“Penn”) focused on the discovery and development of mRNA vaccines that can modulate the body’s normal immune response as possible treatments for certain autoimmune diseases and allergic conditions.

Hanmi Pharmaceuticals (128940.KS), a subsidiary of Hanmi Science (008930.KS) in Korea, announced that the results of large-scale clinical trial with Rosuzet have been published in ‘The Lancet’ and the ‘European Heart Journal’.

Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced three presentations on amyotrophic lateral sclerosis (ALS) as part of the 2023 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference, being held virtually and in Dallas, Tex., March 19-22.

Three new officers and four new board members will be installed immediately upon conclusion of the 2023 Annual Meeting of the American Academy of Dermatology, the world’s largest dermatologic society.

Alvotech (NASDAQ: ALVO) today announced the presentation of two posters related to its clinical studies in support of biosimilarity and clinical comparability of Alvotech’s ATV04 (ustekinumab) and the reference product Stelara® at the 2023 American Academy of Dermatology (AAD) Annual Meeting, March 17-21 in New Orleans.

Healthcare Integrated Technologies, Inc. (“HiTC”), a leading innovator of healthcare technology solutions, is proud to announce the approval of U.S. Patent 11,587,423, issued on February 21, 2023.

Ryan Mitchell, PhD and Director of Business Development at Satellos to highlight SAT-3153 and Satellos’ novel muscle regeneration technology in two forums at this year’s MDA Conference and Summit

Eargo, Inc. (Nasdaq: EAR), a medical device company on a mission to improve hearing health, today announced it will release financial results for the fourth quarter 2022 after market close on March 23, 2023.

Biofrontera Inc. announced that it will be hosting a booth showcasing its innovative, FDA-approved products at the 2023 American Academy of Dermatology Annual Meeting taking place March 17-21, 2023 in New Orleans, LA.

argenx SE announced that an Annual General Meeting of shareholders will be held at 12:00 PM CET on Tuesday, May 2, 2023 at Hilton Amsterdam Schiphol at Schiphol Boulevard 701, 1118 BN Schiphol, the Netherlands.